# Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®

> **NCT03796351** · PHASE1 · COMPLETED · sponsor: **Medy-Tox** · enrollment: 25 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** MT10107
- **DRUG:** Botox

## Key facts

- **NCT ID:** NCT03796351
- **Lead sponsor:** Medy-Tox
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-09
- **Primary completion:** 2013-01
- **Final completion:** 2013-01
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2020-08-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03796351

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03796351, "Pharmacodynamic and Safety of MT10107(Botulinum Type A Neurotoxin) in Comparison to BOTOX®". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT03796351. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*